Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
BBio-Techne Corporation logo
TECHNASDAQ

Bio-Techne Corporation

Bio-Techne Corporation
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Aug 24
Ex-dividend Time TBD
Ex-dividend date
Add to Google Calendar
Filing Time TBD
Annual report (10-K) filing due (est.)
Add to Google Calendar
Aug 12
Earnings 2:30
Full-year earnings
Add to Google Calendar
May 6
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Feb 4
Earnings Time TBD
Q2 earnings
Add to Google Calendar
2025
Nov 5
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Aug 6
Earnings Time TBD
Full-year earnings
Add to Google Calendar
May 7
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Feb 5
Earnings Time TBD
Q2 earnings
Add to Google Calendar
Oct 28
Est.
Earnings 6:30 approx.
Q1 earnings (predicted)
Add to Google Calendar
Nov 5
Est.
Filing Time TBD
Quarterly report (10-Q) filing due (est.)
Add to Google Calendar
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar
Nov 20
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $0.08
Add to Google Calendar
2027
Jan 27
Est.
Earnings 6:30 approx.
Q2 earnings (predicted)
Add to Google Calendar

KPI highlights

FY25
Revenue $1.22B YoY +5.2%
Operating income $102M margin 8.4%
Net income $73M YoY -56.3%
EPS $0.47 YoY -56.1%
P/E 77.2× Rich Rough PER guide (a simplified band — fair value varies by industry and growth stage): <10 Cheap / 10–15 Slightly cheap / 15–22 Fair / 22–35 Slightly rich / ≥35 Rich
ROE —

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 297316317287296311
Operating income 47.438.711747.754.575.5
Net income 34.922.6-17.738.238.051.0
Operating CF 69.732.57.5579.168.458.8

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2014–2026）

機関投資家 111.1%2014201620182020202220242026
機関投資家 111.1%14Q115Q116Q117Q118Q119Q120Q121Q122Q123Q124Q125Q126Q1
機関投資家未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

BlackRock, Inc. 7.8%BlackRock, Inc.VANGUARD CAPITAL M 6.4%VANGUARD CAPITAL MANAGEMENT LLCMORGAN STANLEY 5.4%MORGAN STANLEYFMR LLC 5%FMR LLCVANGUARD PORTFOLIO 4.1%VANGUARD PORTFOLIO MANAGEMENT LLCSTATE STREET CORP 3.7%STATE STREET CORPWELLINGTON MANAGEM 3.2%WELLINGTON MANAGEMENT GROUP LLPGEODE CAPITAL MANA 3.2%GEODE CAPITAL MANAGEMENT, LLCMAVERICK CAPITAL L 3%MAVERICK CAPITAL LTDInvesco Ltd. 2.9%Invesco Ltd.2014201620182020202220242026
BlackRock, Inc. 7.8%BlackRock, Inc.VANGUARD CAPITAL M 6.4%VANGUARD CAPITAL MANAGEMENT LLCMORGAN STANLEY 5.4%MORGAN STANLEYFMR LLC 5%FMR LLCVANGUARD PORTFOLIO 4.1%VANGUARD PORTFOLIO MANAGEMENT LLCSTATE STREET CORP 3.7%STATE STREET CORPWELLINGTON MANAGEM 3.2%WELLINGTON MANAGEMENT GROUP LLPGEODE CAPITAL MANA 3.2%GEODE CAPITAL MANAGEMENT, LLCMAVERICK CAPITAL L 3%MAVERICK CAPITAL LTDInvesco Ltd. 2.9%Invesco Ltd.14Q115Q116Q117Q118Q119Q120Q121Q122Q123Q124Q125Q126Q1

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
その他機関投資家（13F 543社） 64,026,058 40.5% 13F
BlackRock, Inc. 12,264,513 7.8% 13F
VANGUARD CAPITAL MANAGEMENT LLC 10,179,709 6.4% 13F
MORGAN STANLEY 8,532,873 5.4% 13F
FMR LLC 7,899,928 5.0% 13F
VANGUARD PORTFOLIO MANAGEMENT LLC 6,480,337 4.1% 13F
STATE STREET CORP 5,868,396 3.7% 13F
WELLINGTON MANAGEMENT GROUP LLP 5,120,185 3.2% 13F
GEODE CAPITAL MANAGEMENT, LLC 5,112,420 3.2% 13F
MAVERICK CAPITAL LTD 4,739,721 3.0% 13F
Invesco Ltd. 4,588,706 2.9% 13F
Durable Capital Partners LP 4,456,017 2.8% 13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 3,733,248 2.4% 13F
Ruane, Cunniff & Goldfarb L.P. 3,392,001 2.1% 13F
NEUBERGER BERMAN GROUP LLC 3,340,837 2.1% 13F
Capital Research Global Investors 3,188,210 2.0% 13F
UBS Group AG 3,054,343 1.9% 13F
MAIRS & POWER INC 2,750,282 1.7% 13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2,462,487 1.6% 13F
PRICE T ROWE ASSOCIATES INC /MD/ 2,447,331 1.5% 13F
ALLIANCEBERNSTEIN L.P. 2,213,197 1.4% 13F
Sumitomo Mitsui Trust Group, Inc. 2,054,294 1.3% 13F
DF DENT & CO INC 2,043,047 1.3% 13F
DIMENSIONAL FUND ADVISORS LP 1,973,136 1.2% 13F
GOLDMAN SACHS GROUP INC 1,943,534 1.2% 13F
SNYDER CAPITAL MANAGEMENT L P 1,882,298 1.2% 13F

Source：SEC EDGAR（DEF 14A・13D/G・13F）　Classification inferred from disclosed names

F-Score (Piotroski)

5/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 2.9%
✓ Positive operating cash flow $288M
✗ ROA improved YoY 6.2% → 2.9%
✓ Operating CF exceeds net income (accrual quality) OCF $288M / net income $73M
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 76.5% → 75.0%
✗ Current ratio improved 3.87× → 3.46×
✓ No dilution (shares outstanding did not increase) 158,216,258 → 154,972,196
✗ Gross margin improved 66.4% → 64.8%
✓ Asset turnover improved 0.43× → 0.48×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio —
Current ratio 3.5×
Years of positive operating CF 12 of last 12 yrs
Payout ratio 46%
Latest fiscal year result Profit (net income $73M)

Performance history

Last 10 years
$0.0B$0.3B$0.6B$0.9B$1.2B FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 4995636437147399311,1061,1371,1591,220
Operating income 151121136147157237297299207102
Ordinary income ——————————
Net income 10476.112696.122914027228516873.4
Total assets 1,1301,5581,5931,8842,0282,2632,2952,6392,7042,558
Equity 8799501,0791,1661,3811,5631,7021,9672,069—

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

*Split-adjustedUnit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS $0.70$0.51$0.84$0.64$1.50$0.91$1.73$1.81$1.07$0.47
ROE 11.9%8.0%11.7%8.2%16.6%9.0%16.0%14.5%8.1%—
Operating CF 144144170182205352325254299288
Investing CF -108-306-38.7-33727.1-244-96.9-266-203-35.2
Financing CF -23.4189-99.2134-184-62.6-24322.6-122-254
FCF ————153308280216236257

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-03) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data